David Fengas

Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors

Sharan K. Bagal, Kiyoyuki Omoto, David C. Blakemore et al. · Journal of Medicinal Chemistry · 2018 · 52 citations · Full text

Drug Target, Immunology, Molecular Pain +17

Intramolecular metathesis versus Kharasch reactions using the Grubbs metathesis catalyst: towards catalyst economy

James Faulkner, Chris D. Edlin, David Fengas et al. · Tetrahedron Letters · 2005 · 44 citations

Grubbs Metathesis Catalyst, Chemical Engineering, Engineering +6

Atom Transfer Radical Cyclisations Mediated by the Grubbs Ruthenium Metathesis Catalyst

Peter Quayle, David Fengas, Stuart N. Richards · Synlett · 2003 · 42 citations

Bifurcate, tandem ATRC reactions: towards 2-oxabicyclo[4.3.0]nonane core of eunicellins

Madeleine Helliwell, David Fengas, Christopher K. Knight et al. · Tetrahedron Letters · 2005 · 30 citations

Heterocyclic, Tandem Atrc Reactions, Organic Chemistry +2

Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes

Richard Storer, Andy Pike, Nigel A. Swain et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 27 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Chemical Probes +12